Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Olsen, EA; Whittaker, S; Kim, YH; Duvic, M; Prince, HM; Lessin, SR; Wood, GS; Willemze, R; Demierre, MF; Pimpinelli, N; Bernengo, MG; Ortiz-Romero, PL; Bagot, M; Estrach, T; Guitart, J; Knobler, R; Sanches, JA; Iwatsuki, K; Sugaya, M; Dummer, R; Pittelkow, M; Hoppe, R; Parker, S; Geskin, L; Pinter-Brown, L; Girardi, M; Burg, G; Ranki, A; Vermeer, M; Horwitz, S; Heald, P; Rosen, S; Cerroni, L; Dreno, B; Vonderheid, EC.
Clinical end points and response criteria in mycosis fungoides and sezary syndrome: a consensus statement of the international society for cutaneous lymphomas, the United States cutaneous lymphoma consortium, and the cutaneous lymphoma task force of the European organisation for research and treatment of cancer.
J CLIN ONCOL. 2011; 29(18): 2598-2607. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Autor/innen der Med Uni Graz:
Cerroni Lorenzo
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Number of Figures: 1
|
Abstract:
Mycosis fungoides (MF) and Sézary syndrome (SS), the major forms of cutaneous T-cell lymphoma, have unique characteristics that distinguish them from other types of non-Hodgkin's lymphomas. Clinical trials in MF/SS have suffered from a lack of standardization in evaluation, staging, assessment, end points, and response criteria. Recently defined criteria for the diagnosis of early MF, guidelines for initial evaluation, and revised staging and classification criteria for MF and SS now offer the potential for uniform staging of patients enrolled in clinical trials for MF/SS. This article presents consensus recommendations for the general conduct of clinical trials of patients with MF/SS as well as methods for standardized assessment of potential disease manifestations in skin, lymph nodes, blood, and visceral organs, and definition of end points and response criteria. These guidelines should facilitate collaboration among investigators and collation of data from sponsor-generated or investigator-initiated clinical trials involving patients with MF or SS.
Find related publications in this database (using NLM MeSH Indexing)
Clinical Trials as Topic - methods
Humans -
Lymph Nodes - pathology
Mycosis Fungoides - blood
Neoplasm Staging - methods
Outcome Assessment (Health Care) - standards
Quality of Life -
Randomized Controlled Trials as Topic - methods
Research Design -
Severity of Illness Index -
Sezary Syndrome - blood
Skin - pathology
Skin Neoplasms - blood
Treatment Outcome -
Tumor Burden -
Viscera - pathology

© Med Uni Graz Impressum